Fifth Lane Capital’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Fifth Lane Capital’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-58,336	Closed	-$586K	–	205
2023 Q4	$586K	Buy	+58,336	New	+$265K	0.69%	15

Fifth Lane Capital's GRCL Position: Q1 2024 in Review

Fifth Lane Capital sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 58,336 shares — an estimated $586K sold.

Fifth Lane Capital first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $586K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Fifth Lane Capital reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Fifth Lane Capital sold 58,336 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $586K.
Fifth Lane Capital first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Fifth Lane Capital's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $586K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Fifth Lane Capital's 13F filing for Q1 2024, filed 2 May 2024.